Profil
Daniel A. Peisert worked as an Auditor at PricewaterhouseCoopers LLP from 1997 to 1999.
From 1999 to 2001, served as Controller at UBS Securities LLC.
From 1999 to 2005, held the position of Assistant Director at UBS Asset Management (Americas) LLC in 2005.
Worked as an Equity Analyst at Magnetar Capital LLC from 2005 to 2008.
From 2008 to 2012, was Finance Director at Marathon Advisors LLC and Director-Finance & Business Development at Marathon Pharmaceuticals LLC.
Served as Secretary & Director at SureGene LLC from 2012 to 2013.
From 2012 to 2014, worked as a Research Analyst at Cupps Capital Management LLC.
Between 2014 and 2017, held Vice President-US Legacy Pharmaceuticals at Advanz Pharma Corp.
Ltd. and Vice President-US Legacy Business at Advanz Pharma Corp.
(Ontario) from 2016 to 2017.
In 2018, was Senior Vice President-Business Development at Assertio Therapeutics, Inc. Held roles of CFO, Secretary, Treasurer & Director at Zyla Life Sciences LLC.
In 2024, was Director at Assertio Holdings, Inc. Education includes an undergraduate degree from the University of Minnesota, conferred in 1997.
Ehemalige bekannte Positionen von Daniel Peisert
| Unternehmen | Position | Ende |
|---|---|---|
| ASSERTIO HOLDINGS, INC. | Vorstandsvorsitzender | 02.01.2024 |
| ADVANZ PHARMA CORP. LIMITED | Corporate Officer/Principal | 01.09.2017 |
Advanz Pharma Corp. (Ontario)
Advanz Pharma Corp. (Ontario) Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company | Corporate Officer/Principal | 01.09.2017 |
Cupps Capital Management LLC
Cupps Capital Management LLC Investment ManagersFinance Cupps Capital Management offers a variety of investment strategies that pursue an overall growth investment objective, mainly utilizing both US and foreign equity securities (ADRs). They may also invest client assets in other securities, such as ETFs, or derivatives, such as options, if they determine such investments fit within the the client's investment objectives. Cupps Capital also manages assets for affiliated private hedge funds which utilize long/short strategies. The firm's investment strategies include: Large Cap Growth, Mid Cap Growth, Small Cap Growth, All Cap Growth, and Concentrated Growth. | Analyst-Equity | 28.02.2014 |
SureGene LLC
SureGene LLC BiotechnologyHealth Technology Operates as a biotechnology company that engages in the research and development of personalized medicine for mental health | Direktor/Vorstandsmitglied | 01.01.2013 |
Ausbildung von Daniel Peisert
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
UBS Asset Management (Americas) LLC
UBS Asset Management (Americas) LLC Investment ManagersFinance UBS AM offers Equities, Fixed Income, Indexing, and Investment Solutions businesses. The firm provides active investment strategies to their clients and principally employs fundamental analysis in managing client accounts by attempting to identify discrepancies between current market prices and their estimate of fundamental value. | Finance |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
SureGene LLC
SureGene LLC BiotechnologyHealth Technology Operates as a biotechnology company that engages in the research and development of personalized medicine for mental health | Health Technology |
Zyla Life Sciences LLC
Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain | Health Technology |
Cupps Capital Management LLC
Cupps Capital Management LLC Investment ManagersFinance Cupps Capital Management offers a variety of investment strategies that pursue an overall growth investment objective, mainly utilizing both US and foreign equity securities (ADRs). They may also invest client assets in other securities, such as ETFs, or derivatives, such as options, if they determine such investments fit within the the client's investment objectives. Cupps Capital also manages assets for affiliated private hedge funds which utilize long/short strategies. The firm's investment strategies include: Large Cap Growth, Mid Cap Growth, Small Cap Growth, All Cap Growth, and Concentrated Growth. | Finance |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marathon Advisors LLC | |
Magnetar Capital LLC
Magnetar Capital LLC Investment ManagersFinance Magnetar Capital seeks to deliver diversifying returns to investors by investing growth capital in businesses that drive the real economy. The firm invests across geographies, in both public and private transactions. They rely on their robust risk management process at the investment and portfolio level to maintain an anticipated favorable risk-return profile across various market environments. | Finance |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Advanz Pharma Corp. Ltd.
Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Assertio Holdings, Inc.
Assertio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Advanz Pharma Corp. (Ontario)
Advanz Pharma Corp. (Ontario) Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company | Health Technology |
















